Unregistered note exchange with Streeterville Capital
AIM ImmunoTech converted about $1.22 million of a Feb. 16, 2024 Promissory Note into 5,065,840 common shares via exchange agreements dated Aug. 31-Sep. 3, 2026.
The average conversion price was about $0.24 per share; the Promissory Note was satisfied in full as of Sep. 3, 2026.
The shares were issued under Securities Act Section 3(a)(9) as an unregistered exchange with an existing holder.
AIM•
